Nimotuzumab plus platinum-based chemotherapy versus platinum-based chemotherapy alone in patients with recurrent or metastatic nasopharyngeal carcinoma
Lists
Only you see this
Abstract
Our findings suggested that NTZ+CT provides a novel treatment option and prolongs survival significantly for R/M-NPC.
BibTeX
@inproceedings{zhu2020nimotuzumab,
author = {Yunshu Zhu and Sheng Yang and Shengyu Zhou and Jianliang Yang and Yan Qin and Lin Gui and Yuankai Shi and Xiaohui He},
title = {{Nimotuzumab plus platinum-based chemotherapy <i>versus</i> platinum-based chemotherapy alone in patients with recurrent or metastatic nasopharyngeal carcinoma}},
booktitle = {Therapeutic},
year = {2020},
doi = {10.1177/1758835920953738},
}Loading related content...